The next objective of our study was to determine whether similar effects to those found upon BiP heterozigosity in experimental ALS translate to other neurodegenerative disorder, such as PD, in which the activation of the CB1 receptor is also neuroprotective [15,16,17]. The gene discussed is HSPA5; the disease is Parkinson disease.